[1]赵金红,王健,江水清,等.慢性乙型肝炎患者CXC趋化因子Mig的表达[J].南方医科大学学报,2006,(11):1589-1592.
 ZHNA Jin-hong,WANG Jian,JIANG Shui-qing,et al.Expression of chemokine monokine induced by interferon-γ in patients with chronic hepatitis B[J].Journal of Southern Medical University,2006,(11):1589-1592.
点击复制

慢性乙型肝炎患者CXC趋化因子Mig的表达()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2006年11期
页码:
1589-1592
栏目:
论著·临床研究
出版日期:
2000-01-01

文章信息/Info

Title:
Expression of chemokine monokine induced by interferon-γ in patients with chronic hepatitis B
作者:
赵金红; 王健; 江水清; 项桂菊;
安徽理工大学医学院病原学与免疫学教研室; 淮南第二矿工医院感染科; 淮南第二矿工医院感染科 安徽淮南232001; 安徽淮南232001; 安徽淮南232057;
Author(s):
ZHNA Jin-hong1WANG Jian1JIANG Shui-qing2XIANG Gui-ju2 1Department of Etiology and ImmunologyMedical College of Anhui University of Science and TechnologyHuainan 232001China;2Department of Infectious DiseasesSecond Worker’s Hospital of HuainanHuainan 232057China
关键词:
乙型肝炎 趋化因子 Mig 丙氨酸转氨酶 实时PCR
Keywords:
hepatitis B chemokine monokine induced by interferon-γ alanine aminotransferase real-time polymerase chain reaction
分类号:
R512.62
摘要:
目的探讨慢性乙型肝炎(乙肝)患者CXC趋化因子Mig的表达水平及其与HBV-DNA、丙氨酸转氨酶(ALT)的相关性。方法以实时PCR法动态检测慢性乙肝患者外周血单个核细胞(PBMC)内MigmRNA的表达水平,以趋化因子与GAPDH比值为其最终含量。以ELISA法定量检测患者外周血中Mig蛋白含量。结果慢性乙肝患者PBMC内MigmRNA表达水平为0.6883±0.0693,与正常对照组相比差异有显著性(P<0.001)。Mig血清浓度为(609.6±73.8)pg/ml,与正常对照组相比差异有显著性(P<0.05)。患者PBMC内MigmRNA与其外周血中Mig含量显著相关(r=0.7157,P<0.001),外周血中Mig含量与血清ALT水平显著相关(r=0.7220,P<0.001),外周血中Mig含量与血清中HBV-DNA含量显著相关(r=0.7266,P<0.001)。结论慢性乙肝患者MigmRNA及血清Mig含量表达均增高,Mig介导了肝脏炎症细胞浸润,参与了乙肝慢性化病程。
Abstract:
Objective To study the expression levels of monokine induced by interferon-γ(Mig) mRNA and its association with HBV DNA and alanine aminotransferase(ALT) in patients with chronic hepatitis B.Methods The level of Mig mRNA in peripheral blood mononuclear cells(PBMCs) was dynamically detected with real-time quantitative PCR,and the ratio of chemokine/GAPDH was considered to represent the final chemokine level.The plasma level of was measured by enzyme-linked immunosorbent assay(ELISA).Results The mean level of Mig mRNA in PBMCs of the patients with chronic hepatitis B was 0.6883±0.0693,which was significantly higher than that in normal controls(P<0.001).The plasma Mig level in the patients was 609.6±73.8 pg/ml,also significantly higher than that in normal controls(P<0.05).In patients with chronic hepatitis B,the level of Mig mRNA in the PBMCs was significantly correlated with plasma Mig level(r=0.7157,P<0.001),and plasma Mig level was correlated with plasma ALT level(r=0.7220,P<0.001) and plasma HBV DNA level(r=0.7266,P<0.001).Conclusion Both the expression of Mig mRNA in PBMCs and plasma Mig concentration are elevated in patients with chronic hepatitis B.Mig plays an important role in migration of the inflammatory cells to the liver and mediates the development of chronic hepatitis B.?

相似文献/References:

[1]刘刚,卢光琇. 湖南汉族人群CTLA4 基因+49G/A 多态性与乙肝感染和乙肝源性肝癌相关性的初步研究[J].南方医科大学学报,2010,(08):1838.
 LIU Gang,LU Guang-xiu.Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-relatedhepatocellular carcinoma in Hunan Han population[J].Journal of Southern Medical University,2010,(11):1838.
[2]于宏,曹治宸,耿建英,等.干扰素α治疗慢性乙型肝炎患者肝纤维化的实验研究[J].南方医科大学学报,2005,(11):1409.
 YU Hong,CAO Zhi-chen,GENG Jian-ying,et al.Effect of interferon alpha on liver fibrosis in patients with chronic hepatitis B[J].Journal of Southern Medical University,2005,(11):1409.
[3]李梵,闫涛,李克,等.血浆游离DNA用于判断乙型肝炎相关慢加急性肝衰竭的预后—先锋试验结果[J].南方医科大学学报,2014,(02):147.
[4]刘颖,樊蓉,陈简,等.慢性乙型肝炎病毒感染相关肝硬化患者的肾功能及危险因素分析[J].南方医科大学学报,2014,(04):472.
[5]王欣欣,袁国盛,赖静兰,等.HBeAg阳性慢性乙型肝炎患者干扰素治疗24周应答不佳时的治疗方案[J].南方医科大学学报,2015,(06):807.
[6]杨年欢,袁国盛,周宇辰,等.恩替卡韦联合复方鳖甲软肝片治疗慢性乙型肝炎肝纤维化96周的临床疗效[J].南方医科大学学报,2016,(06):775.
[7]诸聪妍,卢观婷,祁婷婷,等.乙型肝炎相关慢加急性肝衰竭患者的长期预后及生存质量[J].南方医科大学学报,2018,(06):736.

备注/Memo

备注/Memo:
安徽省教育厅自然科学基金重点项目(2003kj027zd)~~
更新日期/Last Update: 1900-01-01